+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 35Years +
All Genders
ID07895277

Study Evaluating AI-Assisted Diagnostic and Management Strategies for Pulmonary Nodules to Improve Lung Nodule Care and Outcomes

Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2026-10-26

6000

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This trial focuses on patients with indeterminate pulmonary nodules, which are lung spots that are unclear whether they are cancerous or benign. Researchers are comparing two management strategies one that includes access to an artificial intelligence AI report that analyzes changes in nodules over serial CT scans and estimates cancer risks, and another that follows usual care without the AI report. The main goal is to see if using the AI report reduces the number of lung surgeries that remove benign tissue within 24 months. Additional outcomes include assessing delays in diagnosis, cancer stage, treatment opportunities, complications, and longer-term cancer results. Participants are randomly assigned to one of two groups. One group receives usual care plus the AI report, which analyzes serial CT scans to match nodules, measure changes, and provide malignancy risk estimates. The AI report is generated quickly after randomization and updated with follow-up CT scans during the 24-month intervention period. Clinicians use the AI report alongside CT images but remain responsible for final decisions. The other group receives structured usual care with clinical risk assessments and guideline-based management but without the AI report. Both groups follow the same nodule management pathway and receive appointment reminders. Throughout the study, participants undergo structured longitudinal reviews and quantitative assessments of their nodules using CT imaging. Researchers monitor the occurrence of lung resections yielding benign pathology over 24 months as the primary outcome. Secondary assessments include diagnostic timing, cancer staging, treatment opportunities, complications, and long-term cancer outcomes. Participants provide informed consent and agree to record retrieval and contact for up to five years, allowing comprehensive follow-up. The study aims to improve decision-making in managing indeterminate lung nodules over a two-year period.

CONDITIONS

Brief Title

Longitudinal AI-Assisted Management of Indeterminate Pulmonary Nodules

Research Team

X

Xiaoyu Han

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here